Daiwa Securities Group’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-158
Closed 1308
2022
Q3
$0 Hold
158
﹤0.01% 1329
2022
Q2
$1K Hold
158
﹤0.01% 1271
2022
Q1
$1K Hold
158
﹤0.01% 1287
2021
Q4
$1K Hold
158
﹤0.01% 1321
2021
Q3
$1K Hold
158
﹤0.01% 1257
2021
Q2
$1K Hold
158
﹤0.01% 1173
2021
Q1
$1K Hold
158
﹤0.01% 1179
2020
Q4
$1K Sell
158
-267
-63% -$1.36K ﹤0.01% 1156
2020
Q3
$2K Hold
425
﹤0.01% 1133
2020
Q2
$32K Hold
425
﹤0.01% 928
2020
Q1
$3K Hold
425
﹤0.01% 1129
2019
Q4
$3K Hold
425
﹤0.01% 1140
2019
Q3
$2K Hold
425
﹤0.01% 1119
2019
Q2
$2K Buy
+425
New +$2.17K ﹤0.01% 1143
2019
Q1
Sell
-600
Closed -$6K 1181
2018
Q4
$6K Buy
+600
New +$5.67K ﹤0.01% 1037

Other funds holding ACIU

Daiwa Securities Group's ACIU Position: Q4 2022 in Review

Daiwa Securities Group sold out of AC Immune (ACIU) in Q4 2022, closing a stake of 158 shares.

Daiwa Securities Group first reported a position in ACIU in Q4 2018 and held it in 15 quarters. The position peaked at $32K in Q2 2020. 37 funds tracked by Wall St. Rank hold ACIU as of Q4 2022.

  • Daiwa Securities Group reported no remaining AC Immune position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 158 AC Immune shares in Q4 2022.
  • Daiwa Securities Group first reported a position in AC Immune in Q4 2018 and held it in 15 quarters.
  • Daiwa Securities Group's AC Immune position peaked at $32K in Q2 2020.
  • 37 funds tracked by Wall St. Rank held AC Immune as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.